ILOs

• Understand the treatment options in a patient with type 2 diabetes and appreciate that complications of diabetes and co-morbidity influence management decisions.
• understand the pharmacology of the following treatments for T2DM
  • Metformin
  • Sulphonylureas
  • Pioglitazone,
  • DPP4 inhibitors
  • GLP 1 Receptor agonists
  • SGLT-2 inhibitors.
  • Insulin

• What are the goals of Type 2 DM therapy?
• How do we minimise complications of Type 2 DM?
• Outline the biomedical targets with Type 2 DM therapy
• List the important variables that affect Type 2 DM management
• What lifestyle measures do we advise with Type 2 DM?
• Outline the newer and older treatments for Type 2 DM
• Here is the overall management pathway for Type 2 DM
• Summarise the management pathway for Type 2 DM
• Look what the treatment of hyperglycaemia in Type 2 DM is balancing
• Outline the mechanism of action of metformin, and the benefits and drawbacks
• Outline the mechanism of action of sulfonylureas, and the benefits and drawbacks
• Outline the mechanism of action of DPP-4 inhibitors, and the benefits and drawbacks
• Outline the mechanism of action of SGLT2 inhibitors, and the benefits and drawbacks
• Outline the mechanism of action of thiazolidinediones, and the benefits and drawbacks
• Outline the mechanism of action of GLP-1 receptor agonists, and the benefits and drawbacks
• Outline the mechanism of action of insulin, and the benefits and drawbacks